Posts Tagged 'Risperdal settlement'

Janssen Pharmaceuticals to pay Montana $5.9 M in Risperdal lawsuit settlement

Janssen Pharmaceuticals has agreed to pay the state of Montana $5.9 million in a Risperdal settlement. The state’s attorney general Tim Fox brought the Risperdal lawsuits against the Johnson & Johnson subsidiary, alleging that the company promoted the antipsychotic medication for unapproved and off-label uses. The funds will be divided among hospitals, courts and Risperdal awareness groups.

Read more about the Risperdal settlement…

J&J Said to Pay $2.2 Billion to End Risperdal Sales Probe

Johnson & Johnson has agreed to pay as much as $2.2 billion to settle U.S. probes of the marketing of its Risperdal antipsychotic drug and other medications, two people familiar with the negotiations said. The settlement, which might be announced this week, will include a misdemeanor plea and criminal penalty of as much as $600 million. The accord also would resolve civil claims that J&J paid kickbacks to Omnicare Inc., a company that dispenses drugs at nursing homes, the people said.

Read more about the Risperdal settlements…

J&J ordered to pay $1.1 billion in Risperdal lawsuit

Johnson & Johnson has been ordered to pay $1.1 billion concerning claims by the state of Arkansas that the company hid the health risks of the antipsychotic drug Risperdal from doctors and patients. The verdict is the drug company’s third consecutive loss in Risperdal lawsuits in state courts regarding the marketing of the drug.

Click here to read more…

Johnson & Johnson ordered to pay $1.1 billion penalty in Arkansas Risperdal case

Johnson & Johnson was ordered to pay $1.1 billion by a state judge after an Arkansas jury found the company’s officials misled doctors and patients about the risks of the antipsychotic drug Risperdal. Along with contending that J&J and Janssen defrauded the Medicaid program by failing to properly outline the antipsychotic medicine’s risks, Arkansas officials alleged J&J officials deceptively marketed the drug as safer and better than competing medicines.

Click here to read more…

J&J Said to Face Demand to Lift Risperdal Settlement Offer by $800 Million

Johnson & Johnson (JNJ) faces a U.S. government demand to raise its offer by $800 million from an initial proposal to settle a federal civil investigation into marketing of the antipsychotic Risperdal, according to three people familiar with the matter. The Justice Department is demanding that J&J pay about $1.8 billion to resolve the civil claims by the U.S. and some states, the people said. The U.S. government has been investigating Risperdal sales practices since 2004, including allegations the company marketed the drug for unapproved uses.

Click here to read more…

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 437 other followers

Contact Us:

Hissey Kientz, LLP

9442 Capital of Texas Hwy N.

Arboretum Plaza One, Suite 400

Austin, Texas 78759

Toll-free: (866) 275-4454

Facsimile: (512) 320-9101


Sponsored By:

Hissey Kientz, LLP (Austin, TX)

Attorney Michael Hissey is responsible for the content of this website.